Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
3353TSE Standard

Medical Ikkou Group Co.,Ltd.

メディカル一光グループ Yahoo Finance

Recent & upcoming events

Jul 10
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
May 19
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
Apr 6
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Oct 9
Earnings 2:00 approx.
Q2 earnings announcement (scheduled)
Add to Google Calendar
2027
Jan 8
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Apr 9
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Jul 9
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar
Oct 8
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥54.98B YoY +13.6%
Operating income ¥1.79B margin 3.3%
Net income ¥1.28B YoY +12.5%
EPS ¥339 YoY +12.4%
P/E —
ROE 8.6% Equity ratio 42% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/02 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥56.50B +2.8%
Operating income ¥1.80B +0.7%
Net income ¥1.30B +2.0%
EPS ¥345 +1.9%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY24 Q3FY25 Q2
Revenue ¥8.73B¥11.32B¥11.13B¥11.18B¥11.48B—
Operating income ¥309M¥475M¥481M¥429M¥399M—
Net income ¥245M¥378M¥235M¥436M¥292M—
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

事業法人 44.4%個人 25.1%未開示 27.8%202120222023202420252026
事業法人国内機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

イオン株式会社 27.1%イオン株式会社南野利久 18.9%南野利久ハウス食品グループ本社株式会社 9.6%ハウス食品グループ本社株式会社メディカル一光グループ従業員持株会 4.1%メディカル一光グループ従業員持株会アルフレッサ株式会社 3.2%アルフレッサ株式会社株式会社山陰合同銀行 2.7%株式会社山陰合同銀行菊川 東 2.1%菊川 東東邦ホールディングス株式会社 1.9%東邦ホールディングス株式会社202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
イオン株式会社 1,020,000 27.1% Yuho (EDINET)
南野利久 710,800 18.9% Yuho (EDINET)
ハウス食品グループ本社株式会社 360,000 9.6% Yuho (EDINET)
メディカル一光グループ従業員持株会 153,972 4.1% Yuho (EDINET)
アルフレッサ株式会社 120,000 3.2% Yuho (EDINET)
株式会社山陰合同銀行 100,000 2.7% Yuho (EDINET)
菊川 東 80,000 2.1% Yuho (EDINET)
東邦ホールディングス株式会社 73,000 1.9% Yuho (EDINET)
日本メディカルコンサルタント株式会社 52,000 1.4% Yuho (EDINET)
沢井製薬株式会社 50,000 1.3% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

7/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 3.4%
✓ Positive operating cash flow ¥1.21B
✓ ROA improved YoY 3.3% → 3.4%
✗ Operating CF exceeds net income (accrual quality) OCF ¥1.21B / net income ¥1.28B
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 41.2% → 41.7%
✓ Current ratio improved 1.54× → 1.65×
✓ No dilution (shares outstanding did not increase) 4,070,000 → 3,770,000
✗ Gross margin improved 11.9% → 11.8%
✓ Asset turnover improved 1.41× → 1.46×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 41.7%
Current ratio 1.6×
Years of positive operating CF 10 of last 10 yrs
Payout ratio 273%
Latest fiscal year result Profit (net income ¥1.28B)

Performance history

Last 10 years
0億円137億円275億円412億円550億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 295309312320316336339399484550
Operating income 12.014.110.412.010.312.89.3515.616.917.9
Ordinary income 11.513.810.512.312.013.612.317.518.218.6
Net income 9.5612.47.128.028.368.527.6010.411.312.8
Total assets 249257262262286291275317342376
Equity 81.093.095.5102105119126138147163

Indicators & cash flow

*Split-adjustedUnit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥249¥323¥186¥210¥222¥227¥202¥277¥301¥339
ROE 12.5%14.2%7.5%8.1%8.1%7.8%6.5%8.2%8.3%8.6%
Operating CF 6.5914.35.1618.218.211.413.142.812.012.1
Investing CF 0.041.81-13.5-3.75-11.8-2.16-4.78-32.2-11.3-18.1
Financing CF -12.3-12.34.75-10.95.910.65-23.72.78-10.3-2.84
FCF 6.6316.1-8.3314.56.429.208.3010.60.64-6.06

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓ Dividend grower ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data